LUPO, Luigi Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 7.432
AS - Asia 2.819
EU - Europa 2.711
SA - Sud America 696
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 126
OC - Oceania 7
Totale 13.924
Nazione #
US - Stati Uniti d'America 7.204
SG - Singapore 1.260
IT - Italia 745
CN - Cina 666
BR - Brasile 558
DE - Germania 489
HK - Hong Kong 327
SE - Svezia 315
RU - Federazione Russa 299
UA - Ucraina 195
FI - Finlandia 179
FR - Francia 176
GB - Regno Unito 157
VN - Vietnam 150
IN - India 103
CA - Canada 79
BD - Bangladesh 59
AR - Argentina 56
CI - Costa d'Avorio 50
MX - Messico 39
NL - Olanda 29
IQ - Iraq 28
TR - Turchia 28
CR - Costa Rica 27
BE - Belgio 25
ID - Indonesia 25
ZA - Sudafrica 21
AT - Austria 20
CO - Colombia 20
JP - Giappone 19
TT - Trinidad e Tobago 19
EC - Ecuador 18
PL - Polonia 17
SA - Arabia Saudita 17
PH - Filippine 16
IR - Iran 15
CL - Cile 14
ES - Italia 14
IE - Irlanda 14
MY - Malesia 14
SV - El Salvador 14
CW - ???statistics.table.value.countryCode.CW??? 13
PK - Pakistan 13
HN - Honduras 12
KE - Kenya 12
UZ - Uzbekistan 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
EG - Egitto 9
JO - Giordania 8
PY - Paraguay 8
GT - Guatemala 7
MA - Marocco 7
PR - Porto Rico 7
TN - Tunisia 7
IL - Israele 6
NI - Nicaragua 6
OM - Oman 6
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
ET - Etiopia 5
JM - Giamaica 5
KZ - Kazakistan 5
PE - Perù 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
MK - Macedonia 4
NP - Nepal 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BO - Bolivia 3
GP - Guadalupe 3
LT - Lituania 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
KI - Kiribati 2
KR - Corea 2
LB - Libano 2
SC - Seychelles 2
SN - Senegal 2
TM - Turkmenistan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
EU - Europa 1
GA - Gabon 1
Totale 13.786
Città #
Ashburn 958
Singapore 682
Fairfield 587
San Jose 516
Chandler 505
Jacksonville 424
Woodbridge 389
Hong Kong 325
Milan 312
Cambridge 261
Nyköping 258
Houston 253
Seattle 232
Wilmington 223
Ann Arbor 221
Beijing 199
Dallas 143
Council Bluffs 131
Munich 127
Lawrence 110
Roxbury 109
Rome 104
New York 101
Nanjing 98
Lauterbourg 97
Los Angeles 97
Des Moines 76
Helsinki 73
Boardman 66
Ho Chi Minh City 59
São Paulo 59
Abidjan 50
Santa Clara 49
Princeton 48
Shenyang 45
Bari 42
Brooklyn 42
Inglewood 42
Columbus 33
Toronto 33
Hanoi 32
Jiaxing 32
San Diego 30
Buffalo 29
Figino 28
San Francisco 26
Brussels 24
London 24
Nanchang 24
Chennai 23
Dearborn 23
Eboli 22
San José 22
Marseille 21
Chicago 20
Nuremberg 19
Phoenix 19
Rio de Janeiro 19
Tianjin 19
Turin 19
Montreal 18
Tokyo 18
Paris 17
Belo Horizonte 16
Atlanta 15
Changsha 15
Hebei 15
Redwood City 14
Warsaw 14
Dublin 13
Frankfurt am Main 13
Naples 13
Pune 13
Willemstad 13
Augusta 12
Guangzhou 12
Moscow 12
Nairobi 12
Orem 12
Amsterdam 11
Ardabil 11
Boston 11
Salvador 11
San Salvador 11
Baghdad 10
Bologna 10
Denver 10
Johannesburg 10
Mexico City 10
Vienna 10
Brasília 9
Curitiba 9
Falls Church 9
Kuala Lumpur 9
San Mateo 9
Tashkent 9
Washington 9
Falkenstein 8
Jakarta 8
Leawood 8
Totale 9.123
Nome #
Down-Staging in Liver Transplatation for HCC. Audit of an Experience 237
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 219
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 204
Targeting angiogenesis in biliary tract cancers: An open option 182
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 179
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 177
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 177
D-MELD, a strong and accurate tool to guide Donor -2- Recipient Matching 171
Elective versus emergency full thickness rectal prolapse treatment using a perineal approach - a video vignette 170
Protective colostomy closure: the hazards of a "minor" operation 168
TROMBOPOIETINA E PIASTRINOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO (OLT):RISULTATI PRELIMINARI SU 21 PAZIENTI 166
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 166
A national mandatory-split liver policy: A report from the Italian experience 159
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 155
Down-staging in Liver Transplantation for HCC 154
Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection 150
Improved accuracy of computed tomography in local staging of rectal cancer using water enema 148
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 144
Reliability of clinical judgement in evaluation of the nutritional status of surgical patients 144
Postoperative changes in serum interleukin-2 concentrations 144
Reliable Steroid-Free Immunosuppression in Liver Transplantation 143
Accuratezza diagnostica dello staging dell’HCC nei pazienti con cirrosi: la lezione dei trapianti di fegato 143
Azione della pentossifillina sulla evoluzione in guarigione delle ferite sperimentali nel coniglio 142
Is pyloric function preserved in pylorus-preserving pancreaticoduodenectomy? 141
A Bayesan methodology to improve of early graft loss after liver transplantation derived from the Liver Match study 137
Tempo di ischemia fredda e produzione di trombopoietina(TPO) nel trapianto ortotopico di fegato: risultati preliminari su 21 casi 136
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. 135
Prognostic Value of Neutrophil/Lymphocyte Ratio in Liver Transplantation for HCC 134
Behind D-MELD :the role of primary indication (HCV or HBV) as significant Covariate in the Outcome Prediction after Liver Transplant 133
Safe use of Grafts from HBcAb Positive Donors in Liver Transplantation -Analysis of Matching and Outcome 132
Anatomical hepatic resection using radiofrequency thermoablation in the treatment of primary or secondary liver tumors 132
Platelets and hepatocellular cancer: Bridging the bench to the clinics 132
Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery 131
Laparoscopic management of neuroendocrine tumors: State-of-the-art 129
RUOLO DEL TIPO DI PERFUSIONE NEL PRELIEVO DI FEGATO A SCOPO DI TRAPIANTO 128
EFFECT OF PERIOPERATIVE WHOLE BLOOD VS LEUCOCYTE-DEPLETED BLOOD TRANSFUSION ON SURVIVAL AFTER CURATIVE SURGERY FOR COLORECTAL 127
Fattori prognostici nel trattamento sclerosante delle varici esofagee sanguinanti: Studio preliminare 126
Prediction of mortality by logistic regression analysis in patients with postoperative enterocutaneous fistulae. 126
MELD predictive value of alterations of brain perfusion during liver transplantation 125
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 124
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 124
State of lucid delirium after orthotopic liver transplantation. Clinical case 121
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 121
D-MELD, a powerful Instrument to Optimize Donor -2-Recipient Match.Differences betweenUS and Italy 119
Resection vs radiofrequency ablation for HCC from 3 to 5 cm: A single centre experience on 101 child- pugh class A-B naive patients 118
Basiliximab vs Steroids in liver transplantation immunosuppression. A prospective randomized clinical trial. 117
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 117
RECTAL-CARCINOMA - CT STAGING WITH WATER AS CONTRAST-MEDIUM 117
Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery 116
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 116
[Blood flow assessment with Doppler color ultrasonography in primary and secondary tumors of the liver]. FT Valutazioni flussimetriche con eco color Doppler nei tumori epatici primitivi e secondari. 115
ACUTE PANCREATITIS AFTER ORTOTOPIC LIVER TRANSPLANTATION 115
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosi in 961 patients 115
Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical out come 114
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 113
Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after Intralipid infusion in rabbits 112
Tempo di ischemia fredda e produzione di trombopoietina(TPO)nel trapianto ortotopico di fegato (OLT): studio preliminare sui primi 9 casi. 111
TROMBOPOIETINA (TPO) E TROMBOCITOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO: STUDIO PRELIMINARE SU 9 CASI 111
STATE OF LUCID DELIRIUM AFTER ORTHOTOPIC LIVER TRANSPLANTATION 109
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 109
TROMBOPOIETINA E PIASTRINOPENIA NEI PZ. SOTTOPOSTI A TRAPIANTO DI FEGATO(OLT): RISULTATI PRELIMINARI SU 21 PZ 108
Evaluation of RFA of HCC in patients underwent LTx: Spiral-CT and Pathology on native livers 107
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression 107
LIVER RELATED EVENTS (LRE) IN PATIENTS WITH ESTABLISHED HCV RECURRENT DISEASE AFTER LIVER TRANSPLANTATION COULD BE PREDICTED BY LIVER STIFFNESS MEASUREMENT (LSM). 104
Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor-recipient matching 104
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 104
THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS 103
Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel 101
Hemorheological and microcirculation in healthy and diseased liver after liver transplantation: a review. 101
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 100
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 100
Terapia fibrinolitica nel trattamento delle ulcere venose post-flebitiche 98
Solutions for organ perfusion and storage: haemorheologic aspects 98
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 98
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 98
STUDIO DELL'MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN) NEL TRAPIANTO DI FEGATO 96
The tumor microenvironment regulates HCC growth rate 96
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 95
Reliability and accuracy of the hepatic perfusion index as a diagnostic test for liver metastases. 94
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma 94
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage 94
Valutazione prognostica delle fistole enterocutanee post operatorie: confronto fra due sistemi prognostici 93
Manuale di Metodologia della Ricerca ClinicA 91
OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION. 91
Role of perioperative parenteral nutrition in patients submitted to curative surgery for gastric carcinoma. 91
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 89
[Gene expression of the MAGE-1, -3, and -6 antigens in hepatic carcinoma]. FT Espressione genica degli antigeni MAGE-1, -3, -6 nell'epatocarcinoma. 88
Worse Graft Survival in HCV-Infected Transplanted Females Receiving a Male Donor Graft. The Liver Match Study 87
Limited prognostic value of staging systems for hepatocellular carcinoma on cirrhosis 87
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha 6 beta 4 and alpha 3 beta 1 integrins 86
null 86
Post-surgical trauma acute inflammation. A molecular analysis 84
Reliability of clinical judgement in evaluation of the nutritional-status of surgial patients. 82
null 81
Hepatitis B-core antibody positive donors in Liver Trasplantation and their impact on graft survival:Evidence from the Liver Match cohort study 80
Liver transplantation with hepatitis B core antibodypositive graft under hepatitis b Immunoglobulin and lamivudine prophilaxis 78
Early introduction of subcutaneous hepatitis B immunoglobulin following liver transplantation for hepatitis B virus infection: A prospective, multicenter study 78
Liver stiffness measurments is able to predict graft failure in patients with established HCV recurrence after Liver Transplantation 77
Pushing the limits: Liver Transplantation for HCC beyond the Milan Criteria in the MELD Era (Attraction of forbidden or a rational approach) 76
LONG-TERM OUTCOME OF LIVER RESECTION FOR HCC IN CIRRHOTIC PATIENTS 76
Totale 12.081
Categoria #
all - tutte 58.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022638 0 0 0 0 21 50 39 49 39 38 138 264
2022/20231.350 182 120 84 118 162 196 18 154 245 7 33 31
2023/2024408 33 81 24 36 38 94 21 23 0 6 11 41
2024/20251.977 22 22 159 44 58 189 189 219 102 85 267 621
2025/20263.996 565 211 287 404 481 206 438 126 332 323 115 508
2026/20271.415 123 178 369 719 26 0 0 0 0 0 0 0
Totale 13.924